Kitazato

Kitazato Net Change in Cash

The Net Change in Cash of Kitazato (368A.T) as of Nov 17, 2026 is 986.00 M JPY. In the previous year, Net Change in Cash was 2.38 B JPY — a change of -58.48% (lower).

Net Change in Cash

986.00 MJPY

YoY

-58.48%

Last updated:

Net Change in Cash of Kitazato is 2025 986.00 M JPY. Net Change in Cash of Kitazato was 2024 2.38 B JPY. It decreases by -58.48% lower compared to the previous year.

The Kitazato Net Change in Cash history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Change in Cash
Date
Net Change in Cash
Jan 1, 2023
782.00 M JPY
Jan 1, 2024
2.38 B JPY
Jan 1, 2025
986.00 M JPY
The Kitazato Net Change in Cash history
YEARNet Change in CashYoY
986.00 MJPY-58.48%
2.38 BJPY+203.71%
782.00 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Kitazato Stock analysis

What does Kitazato do? Kitazato Corp manufactures and sells medical devices, reagents, and related products for infertility treatment, specializing in reproductive engineering technology for artificial insemination, in vitro fertilization, and cell cryopreservation. The company produces consumables such as medical equipment and reagents used in in vitro fertilization and intracytoplasmic sperm injection, including media, cryo devices, medical devices, and micro tools. Kitazato Corp distributes its products globally, serving markets in Japan, Europe, the United States, China, and India, with a focus on research reagents and medical equipment for infertility treatment. The firm also manufactures and sells medical equipment parts, provides genetic testing services, and offers medical equipment for the elderly. Additionally, Kitazato Corp engages in market research, acquisition of local licenses, and contract management of living cells, expanding its reach into regenerative medicine and related fields. These services and products target healthcare providers, fertility clinics, and research institutions worldwide. Kitazato Corp's revenue streams include the sale of consumables, medical devices, and reagents, as well as genetic testing and contract management services. The company's global distribution network supports sales across key regions, with a strong emphasis on infertility treatment solutions and regenerative medicine technologies. Kitazato is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Kitazato stock

Net Change in Cash of Kitazato is 986.00 M JPY in 2025.

Net Change in Cash of Kitazato changed from 2.38 B JPY to 986.00 M JPY, representing a -58.48% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Change in Cash Kitazato since 2006 – with annual values, charts, and detailed analysis.

Net change in cash is the total change in cash and equivalents during the period, combining operating, investing, and financing cash flows.

Net Change in Cash's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Change in Cash's Kitazato historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Kitazato

All Key Metrics — Kitazato